<DOC>
	<DOC>NCT00349583</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy on quality of vision and dry eye signs and symptoms in patients undergoing cataract surgery using the ReZoom® multifocal IOL.</brief_summary>
	<brief_title>Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>· Males or females &gt; 50 years old Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL. Likely to complete all study visits and able to provide informed consent Visual potential of 20/25 or better · Prior use of topical cyclosporine Known contraindications to any study medication or ingredients Active ocular diseases or uncontrolled systemic disease Active ocular allergies</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>